Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Because of the specificity of Watson-Crick base pairing, attempts are now being made to use oligodeoxynucleotides (oligos) in the therapy of human disease. However, for a successful outcome, the oligo must meet at least six criteria: (i) the oligos can be synthesized easily and in bulk; (ii) the oligos must be stable in vivo; (iii) the oligos must be able to enter the target cell; (iv) the oligos must be retained by the target cell; (v) the oligos must be able to interact with their cellular targets; and (vi) the oligos should not interact in a non-sequence-specific manner with other macromolecules. Phosphorothioate oligos are examples of oligos that are being considered for clinical therapeutic trials and meet some, but not all, of these criteria. The potential use of phosphorothioate oligos as inhibitors of viral replication is highlighted.

[1]  D. P. Jackson,et al.  Labyrinthine Pattern Formation in Magnetic Fluids , 1993, Science.

[2]  S. Rotenberg,et al.  Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. , 1993, Biochemistry.

[3]  J. Lisziewicz,et al.  Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Sczakiel,et al.  In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. , 1993, Nucleic acids research.

[5]  Qiuyan Zhao,et al.  Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Nerenberg,et al.  Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B. , 1992, Science.

[7]  Y. Cheng,et al.  Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. , 1993, Molecular pharmacology.

[8]  M. Nerenberg,et al.  Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. , 1992, The Journal of biological chemistry.

[9]  G. Zon,et al.  In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Wickstrom,et al.  Down-regulation of c-MYC antigen expression in lymphocytes of Emu-c-myc transgenic mice treated with anti-c-myc DNA methylphosphonates. , 1992, Cancer research.

[11]  D. Ecker,et al.  Implication of RNA structure on antisense oligonucleotide hybridization kinetics. , 1992, Biochemistry.

[12]  C. Roberts,et al.  The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor , 1992, Molecular and cellular biology.

[13]  S. Ferrari,et al.  Antisense Strategies to Characterize the Role of Genes and Oncogenes Involved in Myeloid Differentiation a , 1992, Annals of the New York Academy of Sciences.

[14]  Michael Simons,et al.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo , 1992, Nature.

[15]  D. Melton,et al.  Specificity of antisense oligonucleotides in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  I. D'Agnano,et al.  Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Green,et al.  Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. , 1992, Science.

[18]  E. Kuramoto,et al.  Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. , 1992, Journal of immunology.

[19]  C. Bennett,et al.  Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. , 1992, Molecular pharmacology.

[20]  L B Schook,et al.  Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Mantovani,et al.  B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. , 1992, Blood.

[22]  B. Vogelstein,et al.  Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. , 1992, Oncogene.

[23]  B. Calabretta,et al.  Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides , 1992, The Journal of experimental medicine.

[24]  A. Harel-Bellan,et al.  A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence. , 1992, The Journal of biological chemistry.

[25]  Y. Cheng,et al.  Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. , 1992, Molecular pharmacology.

[26]  W. Paul,et al.  An antisense oligonucleotide complementary to a sequence in I gamma 2b increases gamma 2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion , 1992, The Journal of experimental medicine.

[27]  H. Soreq,et al.  Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Crooke.  Therapeutic applications of oligonucleotides. , 1992, Bio/technology.

[29]  J. Jaroszewski,et al.  A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1. , 1992, Antiviral research.

[30]  M. Watabe,et al.  Binding of oligonucleotides to cell membranes at acidic pH. , 1991, Biochemical and biophysical research communications.

[31]  M. Egholm,et al.  Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. , 1991, Science.

[32]  A. Brussaard,et al.  Functional contribution of neuronal AChR subunits revealed by antisense oligonucleotides. , 1991, Science.

[33]  R. Pepperkok,et al.  Cell growth stimulation by EGF: inhibition through antisense-oligodeoxynucleotides demonstrates important role of casein kinase II. , 1991, Experimental cell research.

[34]  L. Neyses,et al.  Inhibition of endothelin-1 induced myocardial protein synthesis by an antisense oligonucleotide against the early growth response gene-1. , 1991, Biochemical and biophysical research communications.

[35]  W. Stec,et al.  Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates). , 1991, Nucleic Acids Research.

[36]  O. Hermine,et al.  An autocrine role for erythropoietin in mouse hematopoietic cell differentiation. , 1991, Blood.

[37]  R. Hromas,et al.  Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro , 1991, The Journal of experimental medicine.

[38]  A. Periasamy,et al.  Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. , 1991, Nucleic acids research.

[39]  M. Saarma,et al.  Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. , 1991, Science.

[40]  E. Kollar,et al.  EGF antisense oligodeoxynucleotides block murine odontogenesis in vitro. , 1991, Developmental biology.

[41]  J. Hatzfeld,et al.  Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides , 1991, The Journal of experimental medicine.

[42]  S. Freier,et al.  Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. , 1991, The Journal of biological chemistry.

[43]  S. J. Flint,et al.  Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. V. Berkel,et al.  Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution , 1991 .

[45]  J. Blalock,et al.  Antisense oligodeoxynucleotide to the cystic fibrosis gene inhibits anion transport in normal cultured sweat duct cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Agrawal,et al.  Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Chang,et al.  Antisense inhibition of ras p21 expression that is sensitive to a point mutation. , 1991, Biochemistry.

[48]  A. West,et al.  A novel method to modulate desensitization and truncation of luteinizing hormone receptors using antisense oligodeoxynucleotides , 1991, Molecular and Cellular Endocrinology.

[49]  B. Cullen,et al.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. , 1991, Science.

[50]  P. D. Cook,et al.  Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. , 1991, Nucleic acids research.

[51]  B. Hirschbein,et al.  Internucleotide phosphite sulfurization with tetraethylthiuram disulfide. Phosphorothioate oligonucleotide synthesis via phosphoramidite chemistry , 1991 .

[52]  S. Crooke,et al.  Cloning of a phospholipase A2-activating protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Kosik,et al.  The effect of tau antisense oligonucleotides on neurite formation of cultured cerebellar macroneurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  B. Tocqué,et al.  Short modified antisense oligonucleotides directed against Ha‐ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation. , 1991, The EMBO journal.

[55]  J. Blalock,et al.  An antisense oligodeoxynucleotide to growth hormone messenger ribonucleic acid inhibits lymphocyte proliferation. , 1991, Endocrinology.

[56]  R. Letsinger,et al.  Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro. , 1991, Biochemistry.

[57]  D. L. Weeks,et al.  Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Morrison.  Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. , 1991, The Journal of biological chemistry.

[59]  E. Wickstrom,et al.  Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region. , 1991, Oncogene research.

[60]  J. Bag,et al.  Alterations in the expression of muscle-specific genes mediated by troponin C antisense oligodeoxynucleotide. , 1991, Experimental cell research.

[61]  J. Walder,et al.  Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. , 1991, Antisense research and development.

[62]  Y. Cheng,et al.  Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. , 1990, The Journal of biological chemistry.

[63]  F. Ruscetti,et al.  Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide. Evidence for autocrine regulation. , 1990, Journal of immunology.

[64]  H. Piwnica-Worms,et al.  cdc2 gene expression at the G1 to S transition in human T lymphocytes. , 1990, Science.

[65]  T. Tsuruo,et al.  Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line , 1990, International journal of cancer.

[66]  L. V. Van Eldik,et al.  Use of DNA sequence and mutant analyses and antisense oligodeoxynucleotides to examine the molecular basis of nonmuscle myosin light chain kinase autoinhibition, calmodulin recognition, and activity , 1990, The Journal of cell biology.

[67]  J. Florini,et al.  Highly specific inhibition of IGF-I-stimulated differentiation by an antisense oligodeoxyribonucleotide to myogenin mRNA. No effects on other actions of IGF-T. , 1990, The Journal of biological chemistry.

[68]  W. Stec,et al.  Preparation of 35S-labeled polyphosphorothioate oligodeoxyribonucleotides by use of hydrogen phosphonate chemistry. , 1990, Analytical biochemistry.

[69]  J. Toulmé,et al.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids. , 1990, Biochimica et biophysica acta.

[70]  K. Han,et al.  The role of the c-fms oncogene in the regulation of HL-60 cell differentiation. , 1990, Oncogene.

[71]  Y. Cheng,et al.  Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides , 1990, Antimicrobial Agents and Chemotherapy.

[72]  P. Zamecnik,et al.  Inhibition of influenza virus replication by phosphorothioate oligodeoxynucleotides. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Beaucage,et al.  3H-1,2-Benzodithiole-3-one 1,1-dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphorothioates , 1990 .

[74]  Z. Darżynkiewicz,et al.  Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells , 1989, Cell.

[75]  J. Toulmé,et al.  Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity. , 1989, Nucleic acids research.

[76]  J. Maizel,et al.  Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[77]  R. Letsinger,et al.  Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[78]  V. Vlassov,et al.  Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[79]  V. Vlassov,et al.  Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cells , 1989, FEBS letters.

[80]  S. Lederman,et al.  Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. , 1989, Journal of immunology.

[81]  Y. Cheng,et al.  Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase. , 1989, The Journal of biological chemistry.

[82]  F. Cope,et al.  Retinoid receptor antisense DNAs inhibit alkaline phosphatase induction and clonogenicity in malignant keratinocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. Toulmé,et al.  Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides. , 1989, Nucleic acids research.

[84]  H. Mitsuya,et al.  Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[85]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[86]  L. Neckers,et al.  Characterization of oligonucleotide transport into living cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[87]  E. De Clercq,et al.  Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. S. Lee,et al.  Synthetic repeating sequence DNAs containing phosphorothioates: nuclease sensitivity and triplex formation. , 1989, Nucleic acids research.

[89]  S. Broder,et al.  Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. , 1989, Biochemistry.

[90]  L. Neckers,et al.  Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake. , 1988, Gene.

[91]  J. Toulmé,et al.  Antimessenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression--a review. , 1988, Gene.

[92]  U. Littauer,et al.  The inhibition of neurite outgrowth in PC12 cells by tubulin antisense oligodeoxyribonucleotides. , 1988, Gene.

[93]  P. Zamecnik,et al.  Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[94]  E. De Clercq,et al.  Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. , 1988, Antiviral research.

[95]  S. J. Flint,et al.  Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. , 1988, Science.

[96]  J. Walder,et al.  Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[97]  A. Fields,et al.  Human immunodeficiency virus induces phosphorylation of its cell surface receptor , 1988, Nature.

[98]  C. Stein,et al.  Oligodeoxynucleotides as inhibitors of gene expression: a review. , 1988, Cancer research.

[99]  K. Shinozuka,et al.  Physicochemical properties of phosphorothioate oligodeoxynucleotides. , 1988, Nucleic acids research.

[100]  E R Kandel,et al.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[101]  M. Reitz,et al.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[102]  W. Stec,et al.  Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscopic studies of the Rp-Rp, Sp-Sp, and Rp-Sp duplexes, [d(GGSAATTCC)]2, derived from diastereomeric O-ethyl phosphorothioates. , 1986, Nucleic acids research.

[103]  Brian C. Froehler,et al.  Synthesis of DNA via deoxynucleoside H-phosphonate intermediates , 1986, Nucleic Acids Res..

[104]  J. Sodroski,et al.  A second post-transcriptional trans-activator gene required for HTLV-III replication , 1986, Nature.

[105]  R. Bennett,et al.  DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA. , 1985, The Journal of clinical investigation.

[106]  F. Eckstein,et al.  Synthesis of d(GC) and d(CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the B-Z transition. , 1985, Biochemistry.

[107]  W. Stec,et al.  Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides , 1984 .

[108]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[109]  B. Potter,et al.  Stereochemical course of DNA hydrolysis by nuclease S1. , 1983, The Journal of biological chemistry.

[110]  S. Benkovic,et al.  Stereochemical course of the reaction catalyzed by 5'-nucleotide phosphodiesterase from snake venom. , 1979, Biochemistry.

[111]  J. M. Oshorn.  Proc. Nat. Acad. Sei , 1978 .